In the present study, we for the first time demonstrated that CSR inhibits hyperproliferation of IL-6/sIL-6R-stimulated RA-FLS, and that inhibition of JAK2/STAT3 signaling is one of the underlying mechanisms. The gene discussed is IL6; the disease is rheumatoid arthritis.